The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel anti-CD19 chimeric T cell therapy platform ET019002 was safe and effective in inducing CR in blast crisis of CML: A case study.
 
Pengcheng He
No Relationships to Disclose
 
Hong Liu
Employment - Eureka Therapeutics
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Patents, Royalties, Other Intellectual Property - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics
 
Haibo Liu
No Relationships to Disclose
 
Qijing Li
No Relationships to Disclose
 
Mina Luo
No Relationships to Disclose
 
Hui Feng
No Relationships to Disclose
 
Kai Ye
No Relationships to Disclose
 
Bijan Nejadnik
Employment - Eureka Therapeutics
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics
 
Bingyin Shi
No Relationships to Disclose
 
Cheng Liu
Employment - Eureka Therapeutics
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Patents, Royalties, Other Intellectual Property - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics